The Maximum Tolerated Dose and Minimum Effective Dose of OROS® Oxybutynin Compared to Ditropan® (Immediate-release Oxybutynin) in the Treatment of Patients With Urge or Mixed Urinary Incontinence
Sponsor study identifier
interventional
100
0 countries
N/A
Study Start
July 1996
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
February 1997
Date type not reportedThis date has not been verified as actual or estimated.
The purpose of this study is to compare the efficacy and safety of OROS® oxybutynin to that of Ditropan® (immediate-release oxybutynin) for the treatment of patients with urge or mixed urinary incontinence. Oxybutynin is an antispasmodic, anticholinergic medication for the treatment of the symptoms of overactive bladder.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
February 1997
Date type not reportedThis date has not been verified as actual or estimated.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 1996
Date type not reportedThis date has not been verified as actual or estimated.
February 1997
Date type not reportedThis date has not been verified as actual or estimated.
December 22, 2005
Actual (reported)December 26, 2005
Actual (reported)Change from baseline in: the number of urge urinary incontinence episodes per week; total number of urinary incontinence episodes; total void frequency (normal and incontinent)
Incidence of adverse events
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Stoniute A, Madhuvrata P, Still M, Barron-Millar E, Nabi G, Omar MI. Oral anticholinergic drugs versus placebo or no treatment for managing overactive bladder syndrome in adults. Cochrane Database Syst Rev. 2023 May 9;5(5):CD003781. doi: 10.1002/14651858.CD003781.pub3.
Alza Corporation Clinical Trial
Alza Corporation, DE, USA
First Submitted
December 22, 2005
First Posted
December 26, 2005
Study Start
July 1996
Date type not reportedThis date has not been verified as actual or estimated.
Study Completion
February 1997
Date type not reportedMobility and Voiding Exercises in Older Women With Urinary Incontinence (MoVEonUp)
Contact the study team to confirm eligibility.
This date has not been verified as actual or estimated.
Last Updated
May 19, 2011
Record last verified: 2010-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: